Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: HAWAII BIOTECH, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-20 to 2024-04-30
Current total value of award: $26031163
Description: TO DEVELOP A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS.